Nalaganje...
Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
To the best of our knowledge, non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants, have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), affected by malignant disease. However, their use in patients with cancer is increasing, w...
Shranjeno v:
| izdano v: | Anatol J Cardiol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Kare Publishing
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141434/ https://ncbi.nlm.nih.gov/pubmed/31911561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14744/AnatolJCardiol.2019.30766 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|